175 related articles for article (PubMed ID: 34625047)
1. Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line.
Weiner F; Schille JT; Koczan D; Wu XF; Beller M; Junghanss C; Hewicker-Trautwein M; Murua Escobar H; Nolte I
BMC Cancer; 2021 Oct; 21(1):1088. PubMed ID: 34625047
[TBL] [Abstract][Full Text] [Related]
2. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines.
Weiner F; Schille JT; Hein JI; Wu XF; Beller M; Junghanß C; Murua Escobar H; Nolte I
PLoS One; 2021; 16(8):e0256468. PubMed ID: 34432846
[TBL] [Abstract][Full Text] [Related]
5. The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.
Sfikas A; Batsi C; Tselikou E; Vartholomatos G; Monokrousos N; Pappas P; Christoforidis S; Tzavaras T; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
Cell Signal; 2012 Nov; 24(11):2007-23. PubMed ID: 22750558
[TBL] [Abstract][Full Text] [Related]
6. Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells.
Gulappa T; Reddy RS; Suman S; Nyakeriga AM; Damodaran C
Cancer Lett; 2013 Sep; 337(2):177-83. PubMed ID: 23684928
[TBL] [Abstract][Full Text] [Related]
7. Total triterpenoids from Ganoderma Lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis.
Wang T; Xie ZP; Huang ZS; Li H; Wei AY; Di JM; Xiao HJ; Zhang ZG; Cai LH; Tao X; Qi T; Chen DL; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):736-741. PubMed ID: 26489631
[TBL] [Abstract][Full Text] [Related]
8. 4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.
Lee NJ; Oh JH; Ban JO; Shim JH; Lee HP; Jung JK; Ahn BW; Yoon DY; Han SB; Ham YW; Hong JT
Br J Pharmacol; 2013 Mar; 168(5):1133-45. PubMed ID: 23043610
[TBL] [Abstract][Full Text] [Related]
9. KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation.
Zhi H; Zahoor MA; Shudofsky AM; Giam CZ
Oncogene; 2015 Jan; 34(4):496-505. PubMed ID: 24469036
[TBL] [Abstract][Full Text] [Related]
10. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
[TBL] [Abstract][Full Text] [Related]
11. Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells.
Zhong D; Gu C; Shi L; Xun T; Li X; Liu S; Yu L
J Cell Biochem; 2014 Sep; 115(9):1624-35. PubMed ID: 24788582
[TBL] [Abstract][Full Text] [Related]
12. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
Hahm ER; Singh SV
Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
[TBL] [Abstract][Full Text] [Related]
13. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
[TBL] [Abstract][Full Text] [Related]
14. Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis.
Kim SC; Lee WH; Kim SH; Abdulkhayevich AA; Park JW; Kim YM; Moon KH; Lee SH; Park S
Investig Clin Urol; 2021 Jul; 62(4):485-495. PubMed ID: 34190439
[TBL] [Abstract][Full Text] [Related]
15. Trichothecin induces cell death in NF-κB constitutively activated human cancer cells via inhibition of IKKβ phosphorylation.
Su J; Zhao P; Kong L; Li X; Yan J; Zeng Y; Li Y
PLoS One; 2013; 8(8):e71333. PubMed ID: 23936501
[TBL] [Abstract][Full Text] [Related]
16. TGF-β-activated kinase 1 promotes cell cycle arrest and cell survival of X-ray irradiated HeLa cells dependent on p21 induction but independent of NF-κB, p38 MAPK and ERK phosphorylations.
Furusawa Y; Wei ZL; Sakurai H; Tabuchi Y; Li P; Zhao QL; Nomura T; Saiki I; Kondo T
Radiat Res; 2012 Jun; 177(6):766-74. PubMed ID: 22490020
[TBL] [Abstract][Full Text] [Related]
17. NF-κB and JNK mediated apoptosis and G
Zeng GZ; Wang Z; Zhao LM; Fan JT; Tan NH
J Ethnopharmacol; 2018 Jun; 220():220-227. PubMed ID: 29097252
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin.
Hahnvajanawong C; Ketnimit S; Pattanapanyasat K; Anantachoke N; Sripa B; Pinmai K; Seubwai W; Reutrakul V
Biol Pharm Bull; 2012; 35(11):1914-25. PubMed ID: 22972485
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation.
Batsi C; Markopoulou S; Kontargiris E; Charalambous C; Thomas C; Christoforidis S; Kanavaros P; Constantinou AI; Marcu KB; Kolettas E
Biochem Pharmacol; 2009 Jul; 78(1):33-44. PubMed ID: 19447221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
